enVVeno Medical Corporation
NVNO
$2.19
$0.073.30%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -10.40% | -13.84% | 0.72% | 11.63% | -12.96% |
Total Depreciation and Amortization | -5.43% | -5.15% | -3.55% | 5.22% | -2.90% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 13.94% | 4.07% | -10.63% | -13.76% | 31.26% |
Change in Net Operating Assets | -155.83% | 621.74% | -120.00% | 132.81% | -136.03% |
Cash from Operations | -19.39% | -9.42% | -10.12% | 28.63% | -18.04% |
Capital Expenditure | 55.56% | 35.71% | -40.00% | -150.00% | -33.33% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -277.43% | 56.19% | 80.70% | 109.97% | -597.75% |
Cash from Investing | -277.75% | 56.52% | 80.88% | 109.92% | -598.18% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -100.00% | -- | -100.00% | -99.82% | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -100.00% | -- | -100.00% | -99.82% | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -204.03% | 23,437.88% | 105.05% | 1.51% | -671.55% |